SavedAdd your journal

Journals / Türkiye Çocuk Hastalıkları Dergisi / 2012 / Cilt: 6 - Sayı: 2

EVALUATION OF FEBRILE NEUTROPENIA IN CHILDREN WITH ACUTE LEUKEMIA

Akut Lösemili Çocuklarda Febril Nötropeni Ataklarının Değerlendirilmesi

Neşe YARALI
Pamir IŞIK
Abdurrahman KARA
Bahattin TUNÇ
Serdar ÖZKASAP
Esma ALTINEL
Ali BAY
Pages
93–100
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Eight patients (%3.6) died during a FN episode

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this retrospective study, we evaluated 221 febrile neutropenia (FN) episodes in 75 pediatric leukemia cases during empiric antibiotherapy in terms of antibiotic modifications, culture results, treatment period and mortality retrospectively.
📊
Key Findings & Data:One hundred and seventeen (52.9%) episodes were microbiologically and/or clinically documented infections.
💡
Conclusion & Impact:Eight patients (%3.6) died during a FN episode
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Febril nötropeni · çocuk · akut lösemi

Abstract

In this retrospective study, we evaluated 221 febrile neutropenia (FN) episodes in 75 pediatric leukemia cases during empiric antibiotherapy in terms of antibiotic modifications, culture results, treatment period and mortality retrospectively. One hundred and seventeen (52.9%) episodes were microbiologically and/or clinically documented infections. During febrile neutropenia attacks, 14.4% of patients had bacteriemia. Of isolated microorganisms, 73.5% gram-positive, 17.6% were gram-negative and 8.8% fungal pathogens. Fever resolved after mean 7.2 days and mean antibiotic administration time was 13 days. Granulocyte-colony stimulating factor (G-CSF) was used in 102 episodes (46.2%) of FN. Eight patients (%3.6) died during a FN episode

Özet

Bu çalışmada 75 lösemili çocukta gelişen 221 febril nötropeni (FN) atağı retrospektif olarak incelenerek ampirik antibiyoterapi özellikleri, antibiyotik modifikasyonları, kültür sonuçları, tedavi süreleri ve mortaliteleri değerlendirildi. Mikrobiyolojik ve/veya klinik olarak kanıtlanmış enfeksiyon, 117 (%52.9) atakta saptandı. Kan kültüründe mikroorganizma izole edilme oranı %14.4 idi. Bunlardan %73.5’u gram pozitif, %17.6’sı gram negatif ve %8.8’i de fungal patojenlerdi. Ateşin kontrol altına alınma süresi ortalama 7.2 gün ve antibiyotik kullanma süresi ortalama 13 gün idi. Hastalarımızda, granülosit-koloni stimüle edici faktör (G-CSF) 102 FN atağında (%46.2) kullanıldı. Febril nötropeni atağı sırasında sekiz hasta (%3.6) kaybedildi.

🔖

Cite This Article

YARALI, N., IŞIK, P., KARA, A., TUNÇ, B., ÖZKASAP, S., ALTINEL, E., BAY, A. (2022). EVALUATION OF FEBRILE NEUTROPENIA IN CHILDREN WITH ACUTE LEUKEMIA. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 6 - Sayı: 2, 93–100. https://ajindex.com/articles/627584

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Paul M, Yahav D, Fraser A, Leibovici L. Empirical antibiotic mo- notherapy for febrile neutropenia:systematic review and meta- analysis of randomized controlled trials. J Antimicrob Chemoter 2006;57(2):176-89.
  2. Laoprasopwattana K, Pruekprasert P, Laosombat V, Wongchanc- hailert M. Cinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides. Pediatr Hematol Oncol 2007;24:595-606.
  3. Akova M, Paesmans M, Calandra T, Viscoli C. A European Orga- nization for Research and Treatment of Cancer International Anti- microbial Therapy Group Study of Secondary infections in febrile neutropenic patients with cancer. Clin Infect Dis 2005;40(2):239-45.
  4. Sipsas NV, Bodey GP, Kontoyiannis DP. Perspectives for the ma- nagement of febrile neutropenic patients with cancer in the 21st century. Cancer 2005;103(6):1103-13.
  5. Hughes WT, Armstrong D, Bodey GP, Brow EJ, Brown AE, Ca- landra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenia patients with cancer. Clin Infect Dis 2002;34(6):730-51
  6. Giamarellou H, Antoniadou A. Infectious complications of febrile leukopenia. Infect Dis Clin North Am 2001;15(2):457-82. Çelebi S. Çocuklarda Febril Nötropeni. Uludağ Üniversitesi Tıp Fakültesi Dergisi 2003;29(2):35-41.
  7. Hann L, Viscoli C, Paesmans M, Goya H, Glauser M and IATCG of EORTC. A comparison of outcome from febrile neutropenic epi- sodes in children compared with adults:results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treat- ment of Cancer (EORTC). Br J Haematol 1997;99(3):580-8.
  8. Santolaya ME, Alvarez AM, Avilés CL, Becker A, Cofré J, Enríquez N, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fe- ver and neutropenia. Clin Infect Dis 2002;35(6):678-83.
  9. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cu- isenier B, et al. Improved management of invasive pulmonary as- pergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15(1):139-47.
  10. Saugier-Veber P, Devergic A, Sulahian A, Ribaud P, Trao- re F, Bourdeau-Esperou H, et al. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients:result of a 5-year retrospective study. Bone Marrow Trans- plant 1993;12(2):121-4.
  11. Weber C, Maas R, Steiner P, Kramer J, Bumann D, Zander AR,et al. Importance of digital thorac